Lyme Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Lyme Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Lyme Disease Diagnostic Trends and Forecast

The future of the global lyme disease diagnostic market looks promising with opportunities in the hospital & clinic, pathology lab, pharmaceutical industry, and clinical research institute markets. The global lyme disease diagnostic market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are government emphasis on enhancing healthcare facilities, development of novel diagnostic tools for Lyme illness, as well as, an increase in the main players' interest in Lyme disease diagnosis R&D.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Lyme Disease Diagnostic by Segment

The study includes a forecast for the global lyme disease diagnostic by diagnostic test, technology, end use, and region.

Lyme Disease Diagnostic Market by Diagnostic Test [Shipment Analysis by Value from 2018 to 2030]:

• Serological Test
• Nucleic Acid Amplification Techniques
• Urine Antigen Tests
• Lymphocytic Transformation Test
• Immunofluorescent Staining
• PCR Analysis
• Others

Lyme Disease Diagnostic Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Molecular Diagnostics
• Brain MRI
• Spinal Tap
• Echocardiogram
• Electrocardiogram
• Monoclonal Antibodies
• Flow Cytometry
• Gel Microdroplets
• Others

Lyme Disease Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Pathology Labs
• Pharmaceutical Industries
• Clinical Research Institute
• Others

Lyme Disease Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Lyme Disease Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies lyme disease diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lyme disease diagnostic companies profiled in this report include-

• Abbott Laboratories
• Qiagen
• Biosystems
• Bio-Rad Laboratories
• Immunetics
• Roche Diagnostics
• T2 Biosystems
• Graphene Frontiers
• Alere
• Boulder Diagnostics

Lyme Disease Diagnostic Market Insights

Lucintel forecasts that serological tests will remain the largest segment over the forecast period because it focuses on releasing the antibodies that are produced in the body of an infected individual in reaction to antigens.

North America is expected to witness highest growth over the forecast period due to the expanding costs in the healthcare industry and the first release of new goods.

Features of the Global Lyme Disease Diagnostic Market

Market Size Estimates: Lyme disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Lyme disease diagnostic market size by diagnostic test, technology, end use, and region in terms of value ($B).

Regional Analysis: Lyme disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic test, technology, end use, and regions for the lyme disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lyme disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the lyme disease diagnostic market size?

Answer: The global lyme disease diagnostic market is expected to reach an estimated $1.8 billion by 2030.

Q2. What is the growth forecast for lyme disease diagnostic market?

Answer: The global lyme disease diagnostic market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the lyme disease diagnostic market?

Answer: The major drivers for this market are government emphasis on enhancing healthcare facilities, development of novel diagnostic tools for Lyme illness, as well as, an increase in the main players' interest in Lyme disease diagnosis R&D.

Q4. What are the major segments for lyme disease diagnostic market?

Answer: The future of the global lyme disease diagnostic market looks promising with opportunities in the hospital & clinic, pathology lab, pharmaceutical industry, and clinical research institute markets.

Q5. Who are the key lyme disease diagnostic market companies?

Answer: Some of the key lyme disease diagnostic companies are as follows:

• Abbott Laboratories
• Qiagen
• Biosystems
• Bio-Rad Laboratories
• Immunetics
• Roche Diagnostics
• T2 Biosystems
• Graphene Frontiers
• Alere
• Boulder Diagnostics

Q6. Which lyme disease diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that serological tests will remain the largest segment over the forecast period because it focuses on releasing the antibodies that are produced in the body of an infected individual in reaction to antigens.

Q7. In lyme disease diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the expanding costs in the healthcare industry and the first release of new goods.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the lyme disease diagnostic market by diagnostic test (serological test, nucleic acid amplification techniques, urine antigen tests, lymphocytic transformation test, immunofluorescent staining, PCR Analysis, and others), technology (molecular diagnostics, brain MRI, spinal tap , echocardiogram, electrocardiogram, monoclonal antibodies , flow cytometry, gel microdroplets, and others), end use (hospitals & clinics, pathology labs, pharmaceutical industries, clinical research institute , and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?